ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Rivastigmin Patch Sandoz 15, Transdermales Pflaster - 30
63164014 CMSandoz Pharmaceuticals AG
Rivastigmin Patch Sandoz 15, Transdermales Pflaster11.06.2013
Generic13.03.2014
Rivastigmine (N06DA03) 
WHO-DDD 
01.99.30
01.99. 
B  
Yes 
IP 
39.51Yes
    
10 %61.80
7680631640146Synthetika
  
Composition
rivastigminum 27 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte (Beige): ad praeparationem pro 15 cm², cum liberatione 13.3 mg/24h.
Packungsbestandteile
Transdermal patch 
 
Active AgentDose
Rivastigmine27 mg
BAG: Active AgentDose
Rivastigmine27 mg
 
Inactive agentsDoseadditional_information
Acrylic Adhesive  
Butylis Methacrylatis  
Cum Liberatione13.3mg / 24h 
Dimeticone  
Drucktinte (Beige): ad Praeparationem15 cm 
Int-Rac-Alpha-Tocopherolum  
Methylis Methacrylatis Polymerisatum  
Poly(Ethylenis Terephthalas) Trägermaterial
Silicone Adhesive  
 
Source
Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home